Literature DB >> 6259208

Respiratory burst enzyme in human neutrophils. Evidence for multiple mechanisms of activation.

L C McPhail, P M Henson, R B Johnston.   

Abstract

Alteration of the surface of human neutrophils with the nonpenetrating, protein-inactivating agent p-diazobenzenesulfonic acid (DASA) was found to prevent activation of the respiratory burst by some stimuli, but not others. Production of superoxide anion (O2-) stimulated by concanavalin A or the chemotactic peptide formyl-methionyl-leucyl-phenylalanine FMLP was inhibited by DASA pretreatment, whereas O2- production stimulated by phorbol myristate acetate (PMA), sodium fluoride. or the ionophore A23187 was not inhibited by DASA. Pretreatment with DASA inhibited oxygen uptake stimulated by FMLP, but not oxygen uptake stimulated by PMA. DASA reproducibly inhibited activities of two known surface enzymes Mg++-ATPase and alkaline phosphatase, by 45-55% and 60-70%, respectively. The inhibition by DASA of O2- production did not appear to be caused by interference with binding of the affected stimuli, since pretreatment with DASA did not inhibit release of the lysosomal enzymes lysozyme and myeloperoxidase induced by concanavalin A or FMLP. Membrane-rich particulate fractions from neutrophils have been shown to contain NADPH-dependent oxidative activity that is presumably responsible for the phagocytosis-associated respiratory burst of intact cells. The PMA-activated enzyme was susceptible to inhibition of directly exposed to DASA in this particulate fraction. These findings suggest that more than one mechanism exists for activation of the respiratory burst oxidase in human neutrophils, and that the neutrophil possesses at least one oxidase that is not an ectoenzyme.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6259208      PMCID: PMC370621          DOI: 10.1172/JCI110087

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes.

Authors:  R B Johnston; B B Keele; H P Misra; J E Lehmeyer; L S Webb; R L Baehner; K V RaJagopalan
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

2.  The particulate superoxide-forming system from human neutrophils. Properties of the system and further evidence supporting its participation in the respiratory burst.

Authors:  B M Babior; J T Curnutte; B J McMurrich
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

3.  Ecto-enzymes of the guinea pig polymorphonuclear leukocyte. I. Evidence for an ecto-adenosine monophosphatase, adenosine triphosphatase, and -p-nitrophenyl phosphates.

Authors:  J W DePierre; M L Karnovsky
Journal:  J Biol Chem       Date:  1974-11-25       Impact factor: 5.157

4.  Enzymatic basis of metabolic stimulation in leucocytes during phagocytosis: the role of activated NADPH oxidase.

Authors:  P Patriarca; R Cramer; S Moncalvo; F Rossi; D Romeo
Journal:  Arch Biochem Biophys       Date:  1971-07       Impact factor: 4.013

5.  NADPH oxidizing activity in rabbit polymorphonuclear leukocytes: localization in azurophilic granules.

Authors:  P Patriarca; R Cramer; P Dri; L Fant; R E Basford; F Rossi
Journal:  Biochem Biophys Res Commun       Date:  1973-08-06       Impact factor: 3.575

6.  Sulfanilic acid diazonium salt: a label for the outside of the human erythrocyte membrane.

Authors:  H C Berg
Journal:  Biochim Biophys Acta       Date:  1969-06-03

7.  Studies on leukocyte phosphatases. II. Inhibition of leukocyte alkaline phosphatase by amino acids and its reversal by zinc.

Authors:  L R DeChatelet; J V Volk; C E McCall; M R Cooper
Journal:  Clin Chem       Date:  1971-03       Impact factor: 8.327

8.  An isotopic assay for NADPH oxidase activity and some characteristics of the enzyme from human polymorphonuclear leukocytes.

Authors:  L R DeChatelet; L C McPhail; D Mullikin; C E McCall
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

9.  NADPH oxidase deficiency in X-linked chronic granulomatous disease.

Authors:  D C Hohn; R I Lehrer
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

10.  Further characterization of NADPH oxidase activity of human polymorphonuclear leukocytes.

Authors:  L C McPhail; L R DeChatelet; P S Shirley
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

View more
  24 in total

1.  Poly L-histidine. A potent stimulator of superoxide generation in human blood leukocytes.

Authors:  I Ginsburg; R Borinski; M Sadovnic; Y Eilam; K Rainsford
Journal:  Inflammation       Date:  1987-09       Impact factor: 4.092

Review 2.  Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins.

Authors:  P M Henson; R B Johnston
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

3.  Dynamics of chemotactic peptide-induced superoxide generation by human monocytes.

Authors:  E J Leonard; A Shenai; A Skeel
Journal:  Inflammation       Date:  1987-06       Impact factor: 4.092

4.  Stimulus interactions in release of superoxide anion (O2-) from human neutrophils. Further evidence for multiple pathways of activation.

Authors:  J G Bender; D E Van Epps
Journal:  Inflammation       Date:  1985-03       Impact factor: 4.092

5.  Differential inhibition of neutrophil superoxide generation by nonsteroidal antiinflammatory drugs.

Authors:  J C Gay; J N Lukens; D K English
Journal:  Inflammation       Date:  1984-06       Impact factor: 4.092

6.  Manganese-containing superoxide-dismutase deficiency in polymorphonuclear leukocytes of adults with rheumatoid arthritis.

Authors:  C Pasquier; P S Mach; D Raichvarg; G Sarfati; B Amor; F Delbarre
Journal:  Inflammation       Date:  1984-03       Impact factor: 4.092

7.  Comparative superoxide-generating system of granulocytes from blood and peritoneal exudates.

Authors:  W Zimmerli; P D Lew; H J Cohen; F A Waldvogel
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

8.  Bee venom inhibits superoxide production by human neutrophils.

Authors:  S D Somerfield; J L Stach; C Mraz; F Gervais; E Skamene
Journal:  Inflammation       Date:  1984-12       Impact factor: 4.092

9.  Superoxide production by Crohn's disease neutrophils.

Authors:  F T Curran; R N Allan; M R Keighley
Journal:  Gut       Date:  1991-04       Impact factor: 23.059

10.  Synergism among oxidants, proteinases, phospholipases, microbial hemolysins, cationic proteins, and cytokines.

Authors:  I Ginsburg; R Misgav; A Pinson; J Varani; P A Ward; R Kohen
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.